We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current MBX market cap is 41.37M. The company's latest EPS is CAD -0.0003 and P/E is -1000.00.
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 13.41M | 10.53M | 18.59M | 19.08M | 16.52M |
| Operating Income | 1.11M | -3.6M | 4.84M | 2.61M | -2.74M |
| Net Income | 32k | -6.23M | 3.23M | 1.79M | -39k |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 19.63M | 15.6M | 28.83M | 33.15M | 35.65M |
| Total Liabilities | 9.09M | 8.98M | 10.27M | 8.21M | 11.03M |
| Total Equity | 10.54M | 6.62M | 18.56M | 24.94M | 24.62M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | 44k | 9k | 2.11M | 3.47M | -1.1M |
| Investing | -515k | -814k | -622k | -2.03M | -1.02M |
| Financing | 522k | 802k | 8.41M | 2.06M | 229k |
| Market Cap | 41.37M |
| Price to Earnings Ratio | -1000.00 |
| Price to Sales Ratio | 2.5 |
| Price to Cash Ratio | 3.56 |
| Price to Book Ratio | 1.68 |
| Dividend Yield | - |
| Shares Outstanding | 137.91M |
| Average Volume (1 week) | 40.54k |
| Average Volume (1 Month) | 177.9k |
| 52 Week Change | 5.26% |
| 52 Week High | 0.45 |
| 52 Week Low | 0.265 |
| Spread (Intraday) | 0.02 (4.76%) |
| Company Name | Microbix Biosystems Inc |
| Address |
265 watline avenue mississauga, ontario L4Z 1P3 |
| Website | https://www.microbix.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
